Neuehealth Stock Market Value
| NEUE Stock | 5.08 1.55 23.38% |
| Symbol | NeueHealth |
NeueHealth Price To Book Ratio
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 4.07 | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets | Return On Equity |
The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NeueHealth 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NeueHealth's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NeueHealth.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in NeueHealth on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding NeueHealth or generate 0.0% return on investment in NeueHealth over 90 days. NeueHealth is related to or competes with Eastern, RBC Bearings, Nyxoah, Alaska Air, Air Lease, Ryanair Holdings, and Cebu Air. NeueHealth is entity of United States. It is traded as Stock on NYSE exchange. More
NeueHealth Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NeueHealth's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NeueHealth upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.48 | |||
| Information Ratio | 0.0327 | |||
| Maximum Drawdown | 79.77 | |||
| Value At Risk | (4.83) | |||
| Potential Upside | 1.38 |
NeueHealth Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NeueHealth's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NeueHealth's standard deviation. In reality, there are many statistical measures that can use NeueHealth historical prices to predict the future NeueHealth's volatility.| Risk Adjusted Performance | 0.0291 | |||
| Jensen Alpha | 0.2803 | |||
| Total Risk Alpha | 1.5 | |||
| Sortino Ratio | 0.0607 | |||
| Treynor Ratio | 0.4286 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NeueHealth's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NeueHealth Backtested Returns
NeueHealth appears to be very risky, given 3 months investment horizon. NeueHealth has Sharpe Ratio of 0.0521, which conveys that the firm had a 0.0521 % return per unit of risk over the last 3 months. By analyzing NeueHealth's technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please exercise NeueHealth's Mean Deviation of 2.94, risk adjusted performance of 0.0291, and Downside Deviation of 5.48 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, NeueHealth holds a performance score of 4. The company secures a Beta (Market Risk) of 0.52, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NeueHealth's returns are expected to increase less than the market. However, during the bear market, the loss of holding NeueHealth is expected to be smaller as well. Please check NeueHealth's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether NeueHealth's current price movements will revert.
Auto-correlation | -0.2 |
Insignificant reverse predictability
NeueHealth has insignificant reverse predictability. Overlapping area represents the amount of predictability between NeueHealth time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NeueHealth price movement. The serial correlation of -0.2 indicates that over 20.0% of current NeueHealth price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
NeueHealth lagged returns against current returns
Autocorrelation, which is NeueHealth stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NeueHealth's stock expected returns. We can calculate the autocorrelation of NeueHealth returns to help us make a trade decision. For example, suppose you find that NeueHealth has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NeueHealth regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NeueHealth stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NeueHealth stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NeueHealth stock over time.
Current vs Lagged Prices |
| Timeline |
NeueHealth Lagged Returns
When evaluating NeueHealth's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NeueHealth stock have on its future price. NeueHealth autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NeueHealth autocorrelation shows the relationship between NeueHealth stock current value and its past values and can show if there is a momentum factor associated with investing in NeueHealth.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NeueHealth is a strong investment it is important to analyze NeueHealth's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeueHealth's future performance. For an informed investment choice regarding NeueHealth Stock, refer to the following important reports:Check out NeueHealth Correlation, NeueHealth Volatility and NeueHealth Alpha and Beta module to complement your research on NeueHealth. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
NeueHealth technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.